Patient selection for the surgical treatment of resectable colorectal liver metastases.

Abstract

Advances in surgery and chemotherapy regimens have increased the long-term survival of patients with colorectal liver metastases (CRLM). Although liver resection remains an essential part of any curative strategy for resectable CRLM, chemotherapy regimens have also improved the long-term outcomes. However, the optimal timing for chemotherapy regimens remains unclear. Thus, this review addressed key points to aid the decision-making process regarding the timing of chemotherapy and surgery for patients with resectable CRLM. J. Surg. Oncol. 2017;115:213-220. © 2016 Wiley Periodicals, Inc.

DOI: 10.1002/jso.24482

Cite this paper

@article{Arajo2017PatientSF, title={Patient selection for the surgical treatment of resectable colorectal liver metastases.}, author={Raphael Leonardo Cunha Ara{\'u}jo and Rachel Sim{\~o}es Pimenta Riechelmann and Yuman C Fong}, journal={Journal of surgical oncology}, year={2017}, volume={115 2}, pages={213-220} }